<code id='FE6F1C5228'></code><style id='FE6F1C5228'></style>
    • <acronym id='FE6F1C5228'></acronym>
      <center id='FE6F1C5228'><center id='FE6F1C5228'><tfoot id='FE6F1C5228'></tfoot></center><abbr id='FE6F1C5228'><dir id='FE6F1C5228'><tfoot id='FE6F1C5228'></tfoot><noframes id='FE6F1C5228'>

    • <optgroup id='FE6F1C5228'><strike id='FE6F1C5228'><sup id='FE6F1C5228'></sup></strike><code id='FE6F1C5228'></code></optgroup>
        1. <b id='FE6F1C5228'><label id='FE6F1C5228'><select id='FE6F1C5228'><dt id='FE6F1C5228'><span id='FE6F1C5228'></span></dt></select></label></b><u id='FE6F1C5228'></u>
          <i id='FE6F1C5228'><strike id='FE6F1C5228'><tt id='FE6F1C5228'><pre id='FE6F1C5228'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:7
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          AstraZeneca, Daiichi breast cancer treatment succeeds in trial
          AstraZeneca, Daiichi breast cancer treatment succeeds in trial

          AlastairGrant/APLONDON—AstraZenecasaidFridayanexperimentaldrugtampeddowntheprogressionofacertaintype

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Divers poised to search for children washed away in Pennsylvania flash flood

          1:17FloodingisseenhereinNewtownPennsylvaniaaftersomeseverestorms,July16,2023.ABCNewsDiverswerepoised